The Scottish Roslin Cellab, an innovative incubator and contract research organization, which successfully cloned the famous sheep Dolly in 1996 in Edinburgh, Scotland, are meeting Lithuanian scientists and businessmen and discussing potential investment and collaboration with Lithuanians, Invest Lithuania reported.
“We see the outstanding progress and achievements of Lithuanian science and we find a great platform for our collaboration”, says Malcolm Bateman, head of Roslin Cellab.
The company is interested in replicating the Roslin Cellab business model by establishing a satellite company in Lithuania. “Roslin Cellab are very seriously considering establishing a facility in Lithuania and are really willing to develop business with Lithuanians”, said Mantas Nocius, Managing Director of Invest Lithuania, after the meeting with the Scottish guests.
Roslin Cellab have already visited Invest Lithuania, the Innovative Medicine Centre, Biochemistry Institute, and the Santara Science Park in Vilnius and will also meet staff of the Cardiology Institute at Kaunas University of Medicine to learn more about Lithuania’s stem cell capability as well as company’s facility establishment issues.
“With the universities, medical/clinical facilities and plans for a new science park in Vilnius we believe that it is an opportune time to consider establishing our first overseas facility”, says Mr. Bateman.
